Ovarian cancer outcomes may improve with 'dose-dense' chemotherapy
Thursday, June 30, 2011 - 08:30
in Health & Medicine
Dose-dense chemotherapy has shown promise in smaller clinical trials, and now is being investigated in a multi-center, phase III study in which nearly 700 women will participate. Earlier phase II trials pointed to anti-cancer effects for the treatment approach, even when ovarian cancers had become resistant to standard treatment.